Short report: Antigenic relationships between sylvatic and endemic dengue viruses

Nikos Vasilakis, Anna P. Durbin, Amelia P A Travassos Da Rosa, Jorge L. Munoz-Jordan, Robert B. Tesh, Scott Weaver

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.

Original languageEnglish (US)
Pages (from-to)128-132
Number of pages5
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume79
Issue number1
StatePublished - Jul 2008

Fingerprint

Dengue Virus
Immunity
Vaccines
Southeastern Asia
Western Africa
Aedes
Neutralizing Antibodies
Culicidae
Serum
Primates
Viruses
Infection

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Medicine(all)

Cite this

Vasilakis, N., Durbin, A. P., Travassos Da Rosa, A. P. A., Munoz-Jordan, J. L., Tesh, R. B., & Weaver, S. (2008). Short report: Antigenic relationships between sylvatic and endemic dengue viruses. American Journal of Tropical Medicine and Hygiene, 79(1), 128-132.

Short report : Antigenic relationships between sylvatic and endemic dengue viruses. / Vasilakis, Nikos; Durbin, Anna P.; Travassos Da Rosa, Amelia P A; Munoz-Jordan, Jorge L.; Tesh, Robert B.; Weaver, Scott.

In: American Journal of Tropical Medicine and Hygiene, Vol. 79, No. 1, 07.2008, p. 128-132.

Research output: Contribution to journalArticle

Vasilakis, N, Durbin, AP, Travassos Da Rosa, APA, Munoz-Jordan, JL, Tesh, RB & Weaver, S 2008, 'Short report: Antigenic relationships between sylvatic and endemic dengue viruses', American Journal of Tropical Medicine and Hygiene, vol. 79, no. 1, pp. 128-132.
Vasilakis, Nikos ; Durbin, Anna P. ; Travassos Da Rosa, Amelia P A ; Munoz-Jordan, Jorge L. ; Tesh, Robert B. ; Weaver, Scott. / Short report : Antigenic relationships between sylvatic and endemic dengue viruses. In: American Journal of Tropical Medicine and Hygiene. 2008 ; Vol. 79, No. 1. pp. 128-132.
@article{e084b89237754706ab208ddfc8f2af2f,
title = "Short report: Antigenic relationships between sylvatic and endemic dengue viruses",
abstract = "Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.",
author = "Nikos Vasilakis and Durbin, {Anna P.} and {Travassos Da Rosa}, {Amelia P A} and Munoz-Jordan, {Jorge L.} and Tesh, {Robert B.} and Scott Weaver",
year = "2008",
month = "7",
language = "English (US)",
volume = "79",
pages = "128--132",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "1",

}

TY - JOUR

T1 - Short report

T2 - Antigenic relationships between sylvatic and endemic dengue viruses

AU - Vasilakis, Nikos

AU - Durbin, Anna P.

AU - Travassos Da Rosa, Amelia P A

AU - Munoz-Jordan, Jorge L.

AU - Tesh, Robert B.

AU - Weaver, Scott

PY - 2008/7

Y1 - 2008/7

N2 - Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.

AB - Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.

UR - http://www.scopus.com/inward/record.url?scp=46849105286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849105286&partnerID=8YFLogxK

M3 - Article

C2 - 18606776

AN - SCOPUS:46849105286

VL - 79

SP - 128

EP - 132

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 1

ER -